{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T15:20:24Z","timestamp":1770823224090,"version":"3.50.1"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2004,3,30]],"date-time":"2004-03-30T00:00:00Z","timestamp":1080604800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br J Cancer"],"published-print":{"date-parts":[[2004,4]]},"DOI":"10.1038\/sj.bjc.6601704","type":"journal-article","created":{"date-parts":[[2004,4,14]],"date-time":"2004-04-14T11:59:19Z","timestamp":1081943959000},"page":"1538-1542","source":"Crossref","is-referenced-by-count":10,"title":["Grade of recurrent in situ and invasive carcinoma following treatment of pure ductal carcinoma in situ of the breast"],"prefix":"10.1038","volume":"90","author":[{"given":"R R","family":"Millis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S E","family":"Pinder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K","family":"Ryder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R","family":"Howitt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S R","family":"Lakhani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2004,3,30]]},"reference":[{"key":"BF6601704_CR1","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/0046-8177(93)90158-D","volume":"24","author":"DM Barnes","year":"1993","unstructured":"Barnes DM, Dublin EA, Fisher CJ, Levison DA, Millis RR (1993) Immunohistochemical detection of p53 protein in mammary carcinoma: an important new independent indicator of prognosis? Hum Pathol 24: 469\u2013476","journal-title":"Hum Pathol"},{"issue":"S","key":"BF6601704_CR2","first-page":"5A","volume":"19","author":"P Barnes","year":"2000","unstructured":"Barnes P, Wahedna Y, Pinder SE, Lee AHS, Geraghty J, Blamey RW, Ellis IO (2000) Histological features of recurrent disease following treatment for ductal carcinoma in situ of the breast (DCIS). J Pathol 19 (S): 5A","journal-title":"J Pathol"},{"key":"BF6601704_CR3","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/0046-8177(93)90057-N","volume":"24","author":"COC Bellamy","year":"1993","unstructured":"Bellamy COC, McDonald C, Salter DM, Chetty U, Anderson TJ (1993) Noninvasive ductal carcinoma of the breast: the relevance of histologic categorization. Hum Pathol 24: 16\u201323","journal-title":"Hum Pathol"},{"key":"BF6601704_CR4","doi-asserted-by":"publisher","first-page":"2263","DOI":"10.1200\/JCO.2001.19.8.2263","volume":"19","author":"N Bijker","year":"2001","unstructured":"Bijker N, Peterse JL, Duchateau L, Julien J-P, Fentiman IS, Duval C, Di Palma S, Simony-Lafontaine J, de Mascarel I, van de Vijver MJ (2001a) Risk factors for recurrence and metastasis after breast-conserving therapy for ductal carcinoma-in-situ: analysis of European Organization for Research and Treatment of Cancer Trial 10853. J Clin Oncol 19: 2263\u20132271","journal-title":"J Clin Oncol"},{"key":"BF6601704_CR5","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1054\/bjoc.2000.1618","volume":"84","author":"N Bijker","year":"2001","unstructured":"Bijker N, Peterse JL, Duchateau L, Robanus-Maandag EC, Bosch CAJ, DuvaI C, Pilotti S, van de Vijver MJ (2001b) Histological type and marker expression of the primary tumour compared with its local recurrence after breast-conserving therapy for ductal carcinoma in situ. Br J Cancer 84: 539\u2013544","journal-title":"Br J Cancer"},{"key":"BF6601704_CR6","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1002\/(SICI)1096-9896(199903)187:4<396::AID-PATH286>3.0.CO;2-L","volume":"187","author":"H Buerger","year":"1999","unstructured":"Buerger H, Otterbach F, Simon R, Poremba C, Diallo R, Decker T, Riethdorf L, Brinkschmidt C, Dockhorn-Dworniczak B, Boecker W (1999a) Comparative genomic hybridization of ductal carcinoma in situ of the breast-evidence of multiple genetic pathways. J Pathol 187: 396\u2013402","journal-title":"J Pathol"},{"key":"BF6601704_CR7","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1002\/(SICI)1096-9896(199912)189:4<521::AID-PATH472>3.0.CO;2-B","volume":"189","author":"H Buerger","year":"1999","unstructured":"Buerger H, Otterbach F, Simon R, Schafer KL, Poremba C, Diallo R, Brinkschmidt C, Dockhorn-Dworniczak B, Boecker W (1999b) Different genetic pathways in the evolution of invasive breast cancer are associated with distinct morphological subtypes. J Pathol 189: 521\u2013526","journal-title":"J Pathol"},{"key":"BF6601704_CR8","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1136\/jcp.55.8.581","volume":"55","author":"AG Douglas-Jones","year":"2002","unstructured":"Douglas-Jones AG, Logan J, Morgan JM, Johnson R, Williams R (2002) Effect of margins of excision on recurrence after local excision of ductal carcinoma in situ of the breast. J Clin Pathol 55: 581\u2013586","journal-title":"J Clin Pathol"},{"key":"BF6601704_CR9","first-page":"202","volume":"16","author":"IO Ellis","year":"1999","unstructured":"Ellis IO, Pinder SE, Lee AHS, Elston CW (1999) A critical appraisal of existing classification systems of epithelial hyperplasia and in situ neoplasia of the breast with proposals for future methods of categorization: where are we going? Semin Diag Pathol 16: 202\u2013208","journal-title":"Semin Diag Pathol"},{"key":"BF6601704_CR10","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1111\/j.1365-2559.1991.tb00229.x","volume":"19","author":"CW Elston","year":"1991","unstructured":"Elston CW, Ellis IO (1991) Pathological prognostic factors in breast cancer I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology 19: 403\u2013410","journal-title":"Histopathology"},{"key":"BF6601704_CR11","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1002\/(SICI)1097-0142(19990801)86:3<429::AID-CNCR11>3.0.CO;2-Y","volume":"86","author":"ER Fisher","year":"1999","unstructured":"Fisher ER, Dignam J, Tan-Chiu E, Costantino J, Fisher B, Paik S, Wolmark N, for the National Surgical Breast and Bowel Project (NSABP) Collaborating Investigators (1999) Pathologic findings from the National Surgical Adjuvant Breast Project (NSABP) eight-year update of Protocol B-17: intraductal carcinoma. Cancer 86: 429\u2013438","journal-title":"Cancer"},{"key":"BF6601704_CR12","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1093\/ajcp\/106.3.312","volume":"106","author":"NS Goldstein","year":"1996","unstructured":"Goldstein NS, Murphy T (1996) Intraductal carcinoma associated with invasive carcinoma of the breast: a comparison of the two lesions with implications for intraductal carcinoma classification systems. Am J Clin Pathol 106: 312\u2013318","journal-title":"Am J Clin Pathol"},{"key":"BF6601704_CR13","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1038\/bjc.1991.100","volume":"63","author":"WJ Gullick","year":"1991","unstructured":"Gullick WJ, Love SB, Wright S, Barnes DM, Gusterson B, Harris AL, Altman DG (1991) c-erbB-2 protein overexpression in breast cancer is a risk factor in patients with involved and uninvolved lymph nodes. Br J Cancer 63: 434\u2013438","journal-title":"Br J Cancer"},{"key":"BF6601704_CR14","doi-asserted-by":"publisher","first-page":"1740","DOI":"10.1002\/(SICI)1097-0142(19971101)80:9<1740::AID-CNCR7>3.0.CO;2-I","volume":"80","author":"SK Gupta","year":"1997","unstructured":"Gupta SK, Douglas-Jones AG, Fenn N, Morgan JM, Mansel RE (1997) The clinical behaviour of breast carcinoma is probably determined at the preinvasive stage (ductal carcinoma in situ). Cancer 80: 1740\u20131745","journal-title":"Cancer"},{"key":"BF6601704_CR15","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1002\/path.1711590207","volume":"159","author":"A Hitchcock","year":"1989","unstructured":"Hitchcock A, Ellis IO, Robertson JF, Gilmour A, Bell J, Elston CW, Blamey RW (1989) An observation of DNA ploidy, histological grade and immunoreactivity for tumour-related antigens in primary and metastatic breast carcinoma. J Pathol 159: 129\u2013134","journal-title":"J Pathol"},{"key":"BF6601704_CR16","first-page":"167","volume":"11","author":"R Holland","year":"1994","unstructured":"Holland R, Peterse JL, Millis RR, Eusebi V, Faverly D, van de Vijver MJ, Zafrani B (1994) Ductal carcinoma to situ: a proposal for a new classification. Semin Diag Pathol 11: 167\u2013180","journal-title":"Semin Diag Pathol"},{"key":"BF6601704_CR17","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1016\/S0140-6736(99)06341-2","volume":"355","author":"J-P Julien","year":"2000","unstructured":"Julien J-P, Bijker N, Fentiman IS, Peterse JL, Delledonne V, Rouanet P, Avril A, Sylvester R, Mignolet FH, Van Dongen JA (2000) The role of radiotherapy in breast conserving treatment for ductal carcinoma in situ: first results of EORTC randomised phase III trial 10853. Lancet 355: 528\u2013533","journal-title":"Lancet"},{"key":"BF6601704_CR18","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1002\/1097-0142(19890215)63:4<618::AID-CNCR2820630403>3.0.CO;2-J","volume":"63","author":"MD Lagios","year":"1989","unstructured":"Lagios MD, Margolin FR, Westdahl PR, Rose MR (1989) Mammographically detected duct carcinoma in situ. Frequency of local recurrence following tylectomy and prognostic effect of nuclear grade on local recurrence. Cancer 63: 618\u2013624","journal-title":"Cancer"},{"key":"BF6601704_CR19","first-page":"215","volume":"11","author":"OT Lampejo","year":"1994","unstructured":"Lampejo OT, Barnes DM, Smith P, Millis RR (1994) Evaluation of infiltrating ductal carcinomas with a DCIS component: correlation of the histological type of the in situ component with grade of the infiltrating component. Semin Diag Pathol 11: 215\u2013222","journal-title":"Semin Diag Pathol"},{"key":"BF6601704_CR20","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1016\/S0959-8049(97)10072-7","volume":"34","author":"RR Millis","year":"1998","unstructured":"Millis RR, Barnes DM, Lampejo OT, Egan MK, Smith P (1998) Tumour grade does not change between primary and recurrent mammary carcinoma. Eur J Cancer 34: 548\u2013555","journal-title":"Eur J Cancer"},{"key":"BF6601704_CR21","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/S0960-9776(96)90054-5","volume":"5","author":"RR Millis","year":"1996","unstructured":"Millis RR, Bobrow LG, Barnes DM (1996) Immunohistochemical evaluation of biological markers in mammary carcinoma in situ: correlation with morphological features and recently proposed schemes for histological classification. Breast 5: 113\u2013122","journal-title":"Breast"},{"key":"BF6601704_CR22","doi-asserted-by":"publisher","first-page":"11197","DOI":"10.1002\/1097-0142(19951001)76:7<1197::AID-CNCR2820760715>3.0.CO;2-0","volume":"76","author":"DL Page","year":"1995","unstructured":"Page DL, Dupont WD, Rogers LW, Jensen RA, Schuyler PA (1995) Continued local recurrence of carcinoma 15\u201325 years after a diagnosis of low grade ductal carcinoma in situ of the breast treated only by biopsy. Cancer 76: 11197\u201311199","journal-title":"Cancer"},{"key":"BF6601704_CR23","first-page":"47","volume-title":"Progress in Pathology","author":"D Poller","year":"1995","unstructured":"Poller D, Ellis I (1995) Ductal carcinoma in situ (DCIS) of the breast. In Progress in Pathology, Kirkham N, Lemoine N (eds) Vol. 2, pp 47\u201387. Edinburgh: Churchill Livingstone"},{"key":"BF6601704_CR24","first-page":"257","volume":"7","author":"DN Poller","year":"1994","unstructured":"Poller DN, Silverstein MJ, Galea M, Locker AP, Elston CW, Blamey RW, Ellis IO (1994) Ductal carcinoma in situ of the breast: a proposal for a new simplified histological classification, association between cellular proliferation and c-erb B-2 protein expression. Mod Pathol 7: 257\u2013262","journal-title":"Mod Pathol"},{"key":"BF6601704_CR25","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1002\/path.1006","volume":"196","author":"R Roylance","year":"2002","unstructured":"Roylance R, Gorman P, Hanby A, Tomlinson I (2002) Allelic imbalance analysis of chromosome 16q shows that grade I and grade III invasive ductal breast cancers follow different genetic pathways. J Pathol 196: 32\u201336","journal-title":"J Pathol"},{"key":"BF6601704_CR26","doi-asserted-by":"publisher","first-page":"2468","DOI":"10.1002\/1097-0142(19921115)70:10<2468::AID-CNCR2820701013>3.0.CO;2-K","volume":"70","author":"GF Schwartz","year":"1992","unstructured":"Schwartz GF, Finkel GC, Garcia JC, Patchefsky AS (1992) Subclinical ductal carcinoma in situ of the breast: treatment by local excision and surveillance alone. Cancer 70: 2468\u20132474","journal-title":"Cancer"},{"key":"BF6601704_CR27","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1016\/S0046-8177(97)90013-7","volume":"28","author":"MA Scott","year":"1997","unstructured":"Scott MA, Lagios MD, Axelsson K, Rogers LW, Anderson TJ, Page DL (1997) Ductal carcinoma in situ of the breast: reproducibility of histological subtype analysis. Hum Pathol 28: 967\u2013973","journal-title":"Hum Pathol"},{"key":"BF6601704_CR28","doi-asserted-by":"publisher","first-page":"2267","DOI":"10.1002\/(SICI)1097-0142(19960601)77:11<2267::AID-CNCR13>3.0.CO;2-V","volume":"77","author":"MJ Silverstein","year":"1996","unstructured":"Silverstein MJ, Lagios MD, Craig PH, Waisman JR, Lewinsky BS, Colburn WJ, Poller DN (1996) A prognostic index for ductal carcinoma in situ of the breast. Cancer 77: 2267\u20132274","journal-title":"Cancer"},{"key":"BF6601704_CR29","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1056\/NEJM199905133401902","volume":"340","author":"MJ Silverstein","year":"1999","unstructured":"Silverstein MJ, Lagios MD, Groshen S, Waisman JR, Lewinsky BS, Martino S, Gamagami P, Colburn WJ (1999) The influence of margin width on local control of ductal carcinoma in situ of the breast. N Engl J Med 340: 1455\u20131461","journal-title":"N Engl J Med"},{"key":"BF6601704_CR30","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1016\/S0140-6736(95)90982-6","volume":"345","author":"MJ Silverstein","year":"1995","unstructured":"Silverstein MJ, Poller DN, Waisman JR, Colburn WJ, Barth A, Gierson D, Lewinsky B, Gamagami P, Slamon DJ (1995) Prognostic classification of breast ductal carcinoma in situ. Lancet 345: 1154\u20131157","journal-title":"Lancet"},{"key":"BF6601704_CR31","first-page":"1056","volume":"29","author":"JP Sloane","year":"1998","unstructured":"Sloane JP, Amendoeira I, Apostolikas N, Bellocq JP, Bianchi S, Boecker W, Bussolati G, Coleman D, Connolly CE, Dervan P, Eusebi V, De Miguel C, Drijkoningen M, Elston CW, Faverley D, Gad A, Jacquemier J, Lacerda M, Martinez-Penuela J, Munt C, Peterse JL, Rank F, Sylvan M, Tsakraklides V, Zafrani B (1998) Consistency achieved by 23 European pathologists in categorizing ductal carcinoma in situ of the breast using five classifications. European Commission Working Group on Breast Screening Pathology. Hum Pathol 29: 1056\u20131062","journal-title":"Hum Pathol"},{"key":"BF6601704_CR32","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1016\/0046-8177(95)90170-1","volume":"26","author":"N Sneige","year":"1995","unstructured":"Sneige N, McNeese MD, Atkinson EN, Ames FC, Kemp B, Sahin A, Ayala AG (1995) Ductal carcinoma in situ treated with lumpectomy and irradiation: histopathological analysis of 49 specimens with emphasis on risk factors and long term results. Hum Pathol 26: 642\u2013649","journal-title":"Hum Pathol"},{"key":"BF6601704_CR33","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1200\/JCO.1996.14.3.754","volume":"14","author":"LJ Solin","year":"1995","unstructured":"Solin LJ, Kurtz J, Forquet A, Amalric R, Recht A, Bornstein BA, Kuske R, Taylor M, Barrett W, Fowble B, Haffty B, Schultz DR, Yeh I-T, McCormick B, McNeese M (1995) Fifteen-year results of the treatment of breast-conserving surgery and definitive breast irradiation for the treatment of ductal carcinoma in situ of the breast. J Clin Oncol 14: 754\u2013763","journal-title":"J Clin Oncol"},{"key":"BF6601704_CR34","doi-asserted-by":"publisher","first-page":"2532","DOI":"10.1002\/1097-0142(19930415)71:8<2532::AID-CNCR2820710817>3.0.CO;2-0","volume":"71","author":"LJ Solin","year":"1993","unstructured":"Solin LJ, Yeh I-T, Kurtz J, Fourquet A, Recht A, Kuske R, McCormick B, Cross MA, Schultz DJ, Amalric R, LiVolsi VA, Kowalyshyn MJ, Torhorst J, Jacquemier J, Westermann CD, Mazoujian G, Zafrani B, Rosen PP, Goodman RL, Fowble BL (1993) Ductal carcinoma in situ (intraductal carcinoma) of the breast treated with breast-conserving surgery and definitive irradiation: correlation of pathologic parameters with outcome of treatment. Cancer 71: 2532\u20132542","journal-title":"Cancer"},{"key":"BF6601704_CR35","doi-asserted-by":"crossref","unstructured":"UK Coordinating Committee on Cancer Research (UKCCCR) Ductal Carcinoma in situ (DCIS) Working Party (2003) The UK, Australian and New Zealand randomised trial comparing radiotherapy and tamoxifen in women with completely excised ductal carcinoma in situ of the breast. Lancet 362: 95\u2013102","DOI":"10.1016\/S0140-6736(03)13859-7"},{"key":"BF6601704_CR36","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1093\/jnci\/92.4.313","volume":"92","author":"FM Waldman","year":"2000","unstructured":"Waldman FM, DeVries S, Chew KL, Moore DH, Kerlikowske K, Ljung B-M (2000) Chromosomal alterations in ductal carcinomas in situ and their in situ recurrences. J Natl Cancer Inst 92: 313\u2013320","journal-title":"J Natl Cancer Inst"}],"container-title":["British Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/6601704.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/6601704","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/6601704.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T12:56:41Z","timestamp":1684414601000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/6601704"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,3,30]]},"references-count":36,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2004,4]]}},"alternative-id":["BF6601704"],"URL":"https:\/\/doi.org\/10.1038\/sj.bjc.6601704","relation":{},"ISSN":["0007-0920","1532-1827"],"issn-type":[{"value":"0007-0920","type":"print"},{"value":"1532-1827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,3,30]]}}}